AKT1 and Parkinson disease: An in vivo experiment confirmed that nootkatone can inhibit the expression of MAPK3 by activating the PI3K/Akt signaling pathway, reducing neuroinflammation, and ultimately improving the symptoms of rotenone-induced PD [42].